Krish S. Krishnan - SEC Form 4 Insider Trading Activity
President and CEO, Director, 10% Owner
IndividualSelling only55 10b5-1 trades
Filings (90d)
1
1 company
Purchases
0
Sales
69
$41.05M
Filings (all time)
Daily insider-buy trading plan - free during early access. No credit card required.
President and CEO, Director, 10% Owner
Updated Aug 16, 2026
Krish S. Krishnan has filed 1 SEC Form 4 filing across 1 company in the last 90 days - selling. Lifetime open-market sales: $41.05M.
Krish S. Krishnan holds the role of President and CEO at Krystal Biotech, Inc. (KRYS). Krishnan has reported 7 insider filings with the SEC since 2024. The most recent filing was in June 2026.
InsiderAlpha's records for Krish S. Krishnan go back to 2024: 7 primary Form 4 filings, an average of 2.3 per year. 55 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Every role Krish S. Krishnan has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 40 | $312.23 | $12K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 964 | $311.36 | $300K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 2.7K | $310.43 | $823K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 2.8K | $309.49 | $862K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 4.8K | $308.47 | $1.49M | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 11.5K | $307.68 | $3.53M | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 589 | $306.33 | $180K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 544 | $304.81 | $166K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 176 | $303.17 | $53K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 640 | $302.24 | $193K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 320 | $300.75 | $96K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 920 | $266.56 | $245K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 2.4K | $265.59 | $648K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 8.8K | $264.85 | $2.33M | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 2.0K | $263.70 | $539K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 2.4K | $262.44 | $625K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 3.0K | $261.41 | $774K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 3.1K | $260.49 | $815K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 1.4K | $259.87 | $358K | |
| KRYS | Krystal Biotech, Inc. | S - Open-market sale 10b5-1 | 470 | $258.38 | $121K |
Insiders who reported open-market trades at the companies Krish S. Krishnan has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Krish S. Krishnan holds the role of President and CEO at Krystal Biotech, Inc. (KRYS). Krishnan has reported 7 insider filings with the SEC since 2024. The most recent filing was in June 2026.…
1 primary Form 4 filing in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases and 69 open-market sales ($41.05M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Track every insider buy in real time, with AI-scored daily trade ideas and 10b5-1 plan flags.
Free during early access · No credit card required